Welcome to our dedicated page for Axon Enterprise SEC filings (Ticker: AXON), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Axon Enterprise, Inc. filings document operating results and corporate actions for a public safety technology company with Software & Services and Connected Devices activities. Form 8-K reports include shareholder letters on financial results and outlooks, product demand across TASER devices, Axon Body cameras, Axon Evidence, AI products, counter-drone offerings and real-time operations, as well as material-event disclosures tied to capital structure.
Proxy materials cover board composition, shareholder meeting matters, executive compensation and equity awards. Other 8-K and 8-K/A filings record director election updates and the redemption and settlement of 0.50% convertible senior notes due 2027, including the disclosure that no convertible notes remained outstanding after the redemptions and conversions.
Axon Enterprise, Inc. President Joshua Isner reported open-market sales of 13,000 shares of common stock on June 5, 2026. The Form 4 shows 19 separate sale transactions classified as non-derivative common stock sales. Reported sale prices span a range from approximately $481.48 to $501.32 per share, reflecting multiple trades during the day.
Following these transactions, Isner directly holds about 181,785.629 shares of Axon common stock. The filing does not show any related option exercises or derivative security activity, indicating these were straightforward open-market sales from existing share holdings.
AXON ENTERPRISE, INC. executive Elizabeth Reid Coughlin, the company’s Chief Human Officer, reported an open-market sale of Common Stock. She sold 1,554 shares at a price of $485.00 per share. After this transaction, she directly holds 34,023.833 shares of Axon stock, indicating she retained a substantial remaining stake.
Axon Enterprise, Inc. chief revenue officer Cameron Brooks reported an open-market sale of Common Stock. On June 4, 2026, he sold 1,242 shares at a price of $500.00 per share. Following this transaction, he directly holds 49,709.933 shares of Axon Common Stock.
According to a footnote, this sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 8, 2025, indicating the trade was scheduled in advance rather than timed discretionarily.
AXON ENTERPRISE, INC. chief executive officer Patrick W. Smith reported an open-market sale of 20,000 shares of common stock at $500.00 per share. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 12, 2025. Following this sale, Smith directly holds 3,060,997 shares of Axon common stock.
Axon Enterprise, Inc. notice of proposed sale of 13,000 shares of common stock through Wells Fargo Clearing Services on 06/05/2026. The filing shows a dollar amount of $6,349,359.92 associated with that row and Nasdaq as the trading market. The excerpt also lists prior RSU issuances (examples shown) of 7,306, 18,654, 17,156, and 12,363 shares granted on the dates shown. A selling-holder row reports 34,581 shares sold on 03/10/2026 with $18,478,587.82 reflected.
AXON notice of proposed sale under Form 144 filed through Morgan Stanley Smith Barney LLC. The filing lists 1,242 common stock units tied to Restricted Stock Units with an entry date of 05/31/2026 and shows an administrative record date of 06/04/2026. The filing also records a prior 10b5-1 sale by Cameron J. Brooks on 03/09/2026 showing 1,221 common units and a value figure of $690,487.71. This is a routine Form 144 notice of an intended resale by an affiliate; cash‑flow treatment and final sale mechanics are not included in the excerpt.
AXON filed a Form 144 reporting proposed sales of Common stock under compensation arrangements. The notice lists 915 shares tied to Performance Stock Units with a 12/01/2025 reference and 639 shares tied to Restricted Stock Vesting Under a Registered Plan with a 05/31/2026 reference. The brokerage firm listed is Morgan Stanley Smith Barney LLC and the market is identified as NASDAQ.
AXON submitted a notice under Section 144 for the proposed sale of 20,000 common shares. The filing lists the method as Option Exercise with a related date of 11/15/2021. The filing also discloses that Patrick W. Smith sold 10,000 common shares on 03/09/2026 for $5,602,394.00.
AXON ENTERPRISE, INC. Chief Accounting Officer Jennifer H. Mak reported two transactions in common stock tied to tax withholding. On June 1, 2026, a total of about 2,223.9 shares were disposed of to cover tax liabilities from the vesting of restricted stock units under Axon’s equity plans. These are administrative, non–open-market dispositions and do not represent discretionary share sales.